HIV-1 RNA levels in an African population-based cohort and their relation to CD4 lymphocyte counts and World Health Organization clinical staging

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 22, Issue 2, 1999, Pages 167-173

  Morgan, Dilys ^a,c   Rutebemberwa, Alleluiah ^a   Malamba, Samuel ^a   Ross, Amanda ^a   Whitworth, James ^a   Kaleebu, Pontiano ^a   Gotch, Frances ^b  

^a Med Res Cncl Prog AIDS/Uganda V   (Uganda)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

Author keywords

Africa; CD4; Clinical stage; Viral load

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; STAGING; UGANDA; VIRUS DETECTION; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032728525     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199910010-00009     Document Type: Article

References (32)

1. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
2. Wei X, Ghosh KS, Taylor ME, et al. Viral dynamics in human immunodeficiency type 1 infection. Nature 1995;373:117-22.
3. Panteleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus. N Engl J Med 1993;328:327-35.
4. Ho DD. Viral counts count in HIV infection. Science 1996;272: 1124-5.
5. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70.
6. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-5.
7. Riddler SA, Mellors JW. HIV-1 viral load and clinical outcome: review of recent studies. AIDS 1997;11(Suppl 1):S141-8.
8. Mellors JW, Kingsley LA, Rinaldo Jr CR, et al. Quantification of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
9. O'Brien T, Blattner W, Waters D, et al. Serum HIV-1 RNA and time to development of AIDS in the multicenter hemophilia cohort study. JAMA 1996;276:105-10.
10. + T-cell count and function: markers with reciprocal predictive value over time after seroconversion. AIDS 1997;11:1799-806.
11. Dyer JR, Kazembe P, Vernazxa PL, et al. High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in Sub-Saharan Africa. J Infect Dis 1998;177:1742-6.
12. Rizzardini G, Trabattoni D, Saresella M, et al. Immune activation in HIV-infected African individuals. AIDS 1998;12:2387-96.
13. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1998;349: 1868-73.
14. Morgan D, Malamba S, Maude G, et al. An HIV-1 natural history cohort and survival times in rural Uganda. AIDS 1997;11:633-40.
15. World Health Organization. Acquired immune deficiency syndrome (AIDS): interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 1990;65:221-8.
16. Gobbers E, Fransen K, Oosterlaken T, et al. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regards to different HIV-1 subtypes. J Virol Methods 1997;66:293-230.
17. Erbelding EJ, Quinn TC. The clinical utility of viral load monitoring in HIV infection: strengths and limitations. Genitourin Med 1996;72:393-5.
18. Coste J, Montes B, Reynes J, et al. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Med Virol 1996;50:293-302.
19. Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R. Impact of HIV type 1 subtype variation on viral RNA quantification. AIDS Res Hum Retroviruses 1999;15:133-42.
20. Rodriguez RJ, Dayhoff DE, Chang G, et al. Comparison of serum and plasma viral RNA measurements in primary and chronic human immunodeficiency virus type 1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:49-53.
21. Phillips AN, Eron JJ, Bartlett JA, et al. HIV-1 RNA levels and the development of clinical disease. AIDS 1996;10:859-65.
22. Pedersen C, Katzenstein T, Nielsen C, Lundgren J, Gerstoft J. Prognostic value of serum HIV-RNA levels at virologie steady state after seroconversion: relation to CD4 cell count and clinical course of primary infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:93-9.
23. Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 1996;10:167-73.
24. Lee T-H, Sheppard HW, Reis M, Dondero D, Osmond D, Busch MP. Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J Acquir Immune Defic Syndr 1994;7:381-8.
25. Conway B, Montpetit M, Raboud J, et al. Potential applications of proviral load measurement in clinical retrovirology. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10(Suppl 2):S45-50.
26. Craib KJP, Strathdee SA, Hogg RS, et al. Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection. J Infect Dis 1997;176:798-800.
27. 6/1. AIDS 1997;11:53-7.
28. Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologie and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996:335:1091-8.
29. Jurriaans S, Van Gemen B, Weverling GJ, et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 1994;204:223-33.
30. Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998;352:1510-14.
31. Bush CE, Donovan RM, Markowitz N, Baxa D, Kvale P, Saravolatz LD. Gender is not a factor in serum human immunodeficiency virus Type 1 RNA levels in patients with viremia. J Clin Microbiol 1996;34:970-2.
32. Colebunders R, Karita E, Taelman H, Mugyenyi P. Antiretroviral treatment in Africa. AIDS 1997;11(Suppl B):S107-13.